Amniotic Membrane Market Value to Grow $1,563 Million by 2023 : Allied Market Research

"Amniotic membrane has potential advantages not only in ophthalmology but also in surgical wounds and orthopedics. Amniotic membrane transplantation is currently used in the spectrum of ophthalmic indications that are continuously expanding as an effective way to reconstruct the ocular surface. Therefore, the steady increase in amniotic membrane use is expected to complement the amniotic membrane growth worldwide."

A new report "Amniotic Membrane Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023", published by Allied Market Research. The global amniotic membrane market was valued at $812 million in 2016, and is projected to reach $1,563 million by 2023, growing at a CAGR of 9.7% from 2017 to 2023. The cryopreserved amniotic membrane segment accounted for about three-fourth share of the global market in 2016.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/4559

Amniotic membrane is the innermost layer of fetal membranes. Because amniotic membrane has the ability to promote healing, it is used in surgical procedures related to genitourinary, skin, brain and head and neck. Amniotic membrane can also be used as a dressing to relieve eye surface reconstruction and to promote healing of various diseases.

The increase in the elderly population and the increase in amniotic membrane transplantation in a variety of applications are key drivers of this market growth. But the lack of medical professionals is the key to curb market growth. There is also an increased awareness of the effect of amniotic membrane in a variety of surgical procedures that can improve surgical outcomes (eg, anticipated future market growth).

The lyophilized amniotic membrane segment is expected to grow at a significant CAGR during the forecast period as lyophilized amniotic membrane can be stored at ambient temperatures for prolonged periods. Moreover, nearly 240 pieces of amniotic membrane are obtained from a single amnion sheet.

The surgical wounds segment accounted for the maximum share in terms of revenue in 2016 and is expected to grow at a CAGR of 8.9% during the forecast period. This is due to the challenges posed by surgical wounds as they can result in complications such as surgical ulcers.

Ambulatory surgical centers is expected to register a significant growth rate of 9.9% during the forecast period owing to the advantages of ambulatory surgical centers such as less hospital stay and faster recovery post treatment.

Buy now and get FREE One Month Knowledge Tree Subscription (valid till 30 Nov'18): https://www.alliedmarketresearch.com/checkout/510366

Key Findings of the Amniotic Membrane Market:

• The other applications segment accounted for about one-ninth share of the total market in 2016, and is expected to register a CAGR of 10.8% from 2017 to 2023.
• The ophthalmology segment accounted for one-fourth share of the total market in 2016 and is expected to grow at a high CAGR of 11.2% during the forecast period.
• The U.S. dominated the North American amniotic membrane market and is projected to grow at a CAGR of 9.2% from 2017-2023.
• Hospitals end user dominated the amniotic membrane market accounting for one-third share of the total market is expected to grow at a high CAGR of 10.0% during the forecast period.

Asia-Pacific is expected to witness highest growth rate in the global market and is expected to continue this trend throughout the forecast period. This is owing to high population density and rise in disposable income across the countries such as India and China. In addition, rapid growth in geriatric population and increase in number of ophthalmic diseases in the developing economies boost the market growth. For instance, China has 2.5 million individuals suffering from cataract and an estimated one million children suffer from blindness, which is mainly caused due to vitamin A deficiency. This creates an ample demand for upgraded surgeries employing amniotic membrane, fueling the market growth.

The key players operating in the global amniotic membrane market are FzioMed, Inc., Skye Biologics Inc., IOP Ophthalmics, Amniox Medical, Inc., Amnio Technology, LLC, Applied Biologics LLC, Alliqua BioMedical, Inc., Human Regenerative Technologies, LLC, Derma Sciences Inc., and MiMedx Group, Inc. Other players operating in the value chain are AlloCure, Bellicum Pharmaceuticals, Biogen Idec, BIOTIME, Bone Therapeutics, Cell Medica, CESCA THERAPEUTICS, and Fibrocell Science.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.